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http://dx.doi.org/10.1016/j.stemcr.2017.07.012SUMMARYThe advent of large-scale in vitro differentiation of human stem cell-derived insulin-producing cells (SCIPC) has brought us closer to treat-
ing diabetes using stem cell technology. However, decades of experiences from islet transplantation show that ischemia-induced islet cell
death after transplant severely limits the efficacy of the therapy. It is unclear to what extent human SCIPC are susceptible to ischemia. In
this study, we show thatmore thanhalf of SCIPCdie shortly after transplantation. Nutrient deprivation andhypoxia acted synergistically
to kill SCIPC in vitro. Amino acid supplementation rescued SCIPC from nutrient deprivation, likely by providing cellular energy. Gener-
ating SCIPC under physiological oxygen tension of 5% conferred hypoxia resistancewithout affecting their differentiation or function. A
two-pronged strategy of physiological oxygen acclimatization during differentiation and amino acid supplementation during transplan-
tation significantly improved SCIPC survival after transplant.INTRODUCTION
Islet transplantation can be a minimally invasive curative
therapy for type 1 diabetes (T1D) (Barton et al., 2012).
Although rates of insulin independence after islet trans-
plantation have been steadily improving, wide application
of this therapy is limited by the scarcity of eligible deceased
donors and the frequent need of more than one donor per
recipient (Moassesfar et al., 2016; Wisel et al., 2016).
Because islets are detached from the vasculature during
isolation, return of blood supply to transplanted islets is de-
layed relative to whole organ transplants, resulting in pro-
longed ischemia and reduced graft viability that hinders
the efficacy of the therapy.
The high metabolic demand and reliance on aerobic
metabolismmake b cells highly sensitive to proper oxygen-
ation. Oxygen tension in the native pancreas is estimated
to be 5% O2 (Carlsson et al., 1998), but drops below 1%
O2 in islet grafts shortly after transplant (Carlsson et al.,
2001). Hypoxia induces ER stress (Bensellam et al., 2016)
and production of reactive oxygen species in b cells (Clan-
ton, 2007), both of which can lead to b cell death. b cells
that survive hypoxia switch from aerobic glucose meta-
bolism to anaerobic glycolysis that impairs b cell function
(Cantley et al., 2010, 2013; Puri et al., 2013). Many strate-
gies are being evaluated to minimize hypoxia-induced b
cell death and metabolic reprogramming, including
oxygen supplementation, hypoxia preconditioning, pro-
moting neovascularization, and cytoprotection using anti-
oxidants and pro-survival genes (Barkai et al., 2013; Ema-Stem Cell Rep
This is an open access article under the Cmaullee et al., 2005a, 2005b; Faleo et al., 2012; Grey
et al., 2003; Hogan et al., 2012; Pedraza et al., 2012; Plesner
et al., 2005; Yin et al., 2006). However, ischemia also results
in nutrient deprivation that can affect cell viability and
function. The extent to which nutrient deprivation affects
b cell survival, alone or in combination with hypoxia, is
unknown.
Recent advances in the generation of functional human
stem cell-derived insulin-producing cells (SCIPC) have
raised the possibility of providing a renewable source of b
cells for transplantation, overcoming the shortage of hu-
man donors (Pagliuca et al., 2014; Rezania et al., 2014;
Russ et al., 2015; Yoshihara et al., 2016). Currently a clinical
trial is ongoing to evaluate the safety and efficacy of human
embryonic stem cell-derived pancreatic progenitor cells
(NCT02239354). However, how human SCIPC respond to
hypoxia and nutrient deprivation has not been investi-
gated. SCIPC are generated in artificial culture media under
atmospheric 21% oxygen and are relatively immature
when compared with islets isolated from pancreata. Thus,
their requirements for nutrients and oxygen may be
distinct from those for mature islets. In addition, SCIPC
produced using current protocols, while being glucose
responsive, are not fully mature b cells, and exposure to
ischemia may alter their differentiation state. In this trial,
pancreatic progenitor cells are encapsulated to provide an
immune-protective barrier and prevent the escape of
potentially undifferentiated cells. While encapsulation
provides a much-needed safety assurance in early clinical
trials using stem cell-derived cellular products, it furtherorts j Vol. 9 j 807–819 j September 12, 2017 j ª 2017 The Authors. 807
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
BA DC E
Luminescence
0.8
0.6
0.4
0.2
Luminescence
0.8
0.6
0.4
0.2
×106×106
Figure 1. Survival of Mature Mouse Islets and Human SCIPC after Transplant
(A) Representative bioluminescence images of B6.MIP.Luc islets transplanted into non-diabetic B6 albino mice under the kidney capsule
(KC, n = 10) or subcutaneously (SQ, n = 3).
(B) Bioluminescent intensity (BLI) of islet grafts over time is shown as percentage of day 0. The data are a compilation of results from three
independent experiments.
(C) Representative bioluminescence images of SCIPC.LUC transplanted into non-diabetic NSG mice under KC (n = 8) or SQ (n = 10).
(D) BLI of SCIPC grafts over time are shown as percentage of day 0. The data are a compilation of results from five independent exper-
iments. For (B) and (D), a Wilcoxon signed-rank test is used to determine the statistical significance between each post-transplant data
point with a theoretical value of 100%. A t test is used to compare KC and SQ grafts at each time point.
(E) SCIPC grafts were harvested 7 days after transplant, and percentage of GFP+ human cells were quantified using flow cytometry. Data
shown are a summary of three independent experiments (n = 10). A paired t test was used to compare the two groups.
For (B), (D), and (E), data are expressed as mean ± SEM. *p < 0.05; ****p < 0.0001.exacerbates ischemia and graft failure (Weir, 2013). Thus,
there is a pressing need to determine SCIPC response to
ischemia to better realize the therapeutic potential of
stem cell technology. In this study, we compared the effects
of hypoxia and nutrient deprivation on human SCIPC and
mature islets. Importantly, we offer strategies to minimize
damage by these two insults to optimize engraftment of
SCIPC.RESULTS
Attrition of SCIPC and Mature Islet Grafts after
Transplant
To enable quantitative measurement of SCIPC survival
after transplant, we generated a human embryonic stem
cell line that expresses a firefly luciferase gene under the
control of the constitutive endogenous AAVS1 loci using
TALEN technology. Formature islets, we used islets isolated
from mice that express a firefly luciferase transgene under
the control of the endogenous mouse insulin promoter
(B6.MIP-Luc) (Park and Bell, 2009). We transplanted lucif-
erase-expressing SCIPC clusters into NSG mice and
B6.MIP-Luc islets into B6 albino mice under the kidney
capsules (KC) or in the subcutaneous (SQ) space. We moni-
tored graft survival over time using bioluminescent imag-
ing. Graft mass of both SCIPC and mouse islets dropped
sharply within the first 3 days and stabilized by day 7 after
transplant (Figure 1). SCIPC grafts survived better than
mature islets, and the highly vascularized KC site afforded808 Stem Cell Reports j Vol. 9 j 807–819 j September 12, 2017better graft survival when compared with the SQ site.
Nonetheless, approximately 50% of SCIPC graft mass was
lost within 1 week after transplant.
SCIPC clusters consist of a mix of b cells and pancreatic
progenitor cells at different differentiation stages (Russ
et al., 2015). To specifically monitor the fate of insulin-pro-
ducing b cells, we use the Mel1INS-GFP/WT cell line (Micallef
et al., 2012) that has a GFP transgene knocked into one
allele of the insulin locus, thus specifically marking insu-
lin-producing cells with GFP. We generated SCIPCINS-GFP
and determined the percentages of GFP+ b cells before
and after transplantation under the KC, a site that showed
60% overall SCIPC survival. The fraction of cells expressing
GFP among viable cells significantly decreased by 67% (Fig-
ure 1E). Thus, although SCIPC as a whole population are
more resistant than mature islets to post-transplant graft
loss, the more differentiated insulin-producing cells are
selectively lost when compared with pancreatic progeni-
tors within the heterogeneous SCIPC population.Impact of Nutrient Deprivation on Viability and
Function of SCIPC and Islets
Ischemia leads to both hypoxia and nutrient deprivation. It
has been well documented that hypoxia is detrimental to
mouse (Bensellam et al., 2016) and human islets (Moritz
et al., 2002). However, the effect of nutrient deprivation
on islets is less clear. To study the impact of nutrient depri-
vation without the confounding contribution of hypoxia
and to provide a system for mechanistic studies and
screening for interventions, we developed an in vitro assay
of nutrient deprivation for SCIPC and islets. We created an
in vitro nutrient-limiting environment by increasing the
density of SCIPC or islets cultured in complete medium
while keeping oxygen levels constant (Figure S1). We
cultured mouse islets expressing GFP under the mouse in-
sulin promoter at various densities and monitored GFP
fluorescence over time using time-lapse video (Figures
S2A and S2B). The islet-associated GFP signal dropped
sharply within 6 hr under high density, particularly in
the center of islets (Figures S2A and S2C).
These results are consistent with the interpretation that
islets cultured under high density suffer from nutrient
deprivation. A hallmark of cellular nutrient deprivation is
the activation of autophagy (Fujimoto et al., 2009), which
can be detected by the formation of autophagosomes. We
thus examined autophagosome formation by using islets
from mice expressing an autophagosome reporter trans-
gene, light chain 3-GFP fusion protein (Martino et al.,
2012). Microscopic imaging and flow cytometry revealed
a significant increase of GFPbright autophagosomes in cells
cultured at high density (Figures S3A and S3B), consistent
with cells undergoing nutrient deprivation.
To quantitate cell death and allow analysis of non-trans-
genic cells, we stained islets and SCIPC clusters with the
viability dye propidium iodide (PI) and determined the
percentage of PI+ dead cells using flow cytometry. SCIPC,
human islets, and mouse islets displayed a density-depen-
dent increase in cell death after 6 hr of incubation (Fig-
ure 2A). However, SCIPC were more resilient to increases
in cell density, as a 3-fold higher density was necessary to
induce similar levels of cell death seen with mature human
or mouse islets.
High-density culture may kill cells in ways other than
depletion of nutrients, such as localized hypoxia and or
accumulation of metabolic waste. Therefore, we simulated
nutrient deprivation alternatively by diluting culture
mediawith PBSwhile keeping the culture density constant.
SCIPC andmouse islets showed a significant increase in cell
death with media dilution (Figure 2B) comparable with
high-density cultures. Lastly, we assessed islet function
after exposure to high-density conditions by measuring
in vitro glucose-stimulated insulin secretion (GSIS). Mouse
islets maintained in low-density conditions had a stimula-
tion index of more than 20, whereas islets cultured at high
density showed no increase (Figures 2C and 2D). Together,
these results show that short exposure to nutrient depriva-
tion can independently kill mature islets and SCIPC
without overt hypoxia.
Impact of Hypoxia on SCIPC and Islet Viability
To assess the effect of hypoxia on cell survival in vitro,
we cultured SCIPC, human islets, and mouse islets at 1%oxygen to simulate hypoxic conditions they may en-
counter post transplant. More than 50% of human and
mouse islets died, whereas SCIPC showed less than 20%
death (Figure 2E).
We then compared the rate of cell death when SCIPC,
human islets, and mouse islets were challenged with hyp-
oxia and nutrient deprivation individually or in combina-
tion. While human and mouse islets were vulnerable to
either insult alone, and exposure to both resulted in an ad-
ditive effect resulting in >90% cell death (Figure 2F), SCIPC
were more resistant to individual challenges, but the com-
bination of both acted synergistically, killing most SCIPC
(Figure 2F). Together, these results suggest that SCIPC are
more resilient than mature islets when exposed to individ-
ual components of ischemia, but are similarly vulnerable to
their combined actions. Thus, optimal therapeutic out-
comes using SCIPC will require strategies to mitigate the
impacts of nutrient deprivation and hypoxia.
Mitigating Nutrient Deprivation-Induced Cell Death
In Vitro
We next set out to identify the limiting nutrients in high-
density cultures by adding individual nutrients. Addition
of glucose to high-density SCIPC and mouse islet cultures
had no effect on cell survival (Figure 3A). Next, we supple-
mented cultures with amino acids.We selected alanine and
glutamine because they are themost abundant amino acids
in the interstitial fluid (Curi et al., 2005); cysteine for
its cytoprotective effects on islets (Rasilainen et al., 2002),
and leucine, tryptophan, and methionine for their ability
to inhibit starvation-induced autophagy in hepatocytes
(Kanazawa et al., 2004). Supplementation of alanine and
tryptophan greatly enhanced mouse islet survival in
high-density cultures, glutamine, cysteine, and leucine
offered moderate protection, whereas methionine had no
effect (Figure 3B). Similarly, alanine and glutamine supple-
mentation preserved SCIPC and human islet survival
under high-density conditions (Figure 3C). These results
show that addition of single amino acids can efficiently
protect islets and SCIPC from nutrient deprivation.
Mechanisms of Amino Acid Protection against
Nutrient Deprivation
Amino acids have a multitude of cellular effects including
serving as precursors of protein synthesis, regulating gene
expression, providing energy, and stimulating insulin
secretion in b cells (Cunningham et al., 2005; Curi et al.,
2005; Dixon et al., 2003; Eto et al., 1999). Amino acids acti-
vate protein synthesis via mammalian target of rapamycin
(mTOR) (Gulati et al., 2008), which is inhibited under
nutrient-limiting conditions (Yu et al., 2010). Thus, we
investigated the role of mTOR in amino acid-mediated pro-
tection of SCIPC and islets against nutrient deprivation.WeStem Cell Reports j Vol. 9 j 807–819 j September 12, 2017 809
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Figure 2. Impact of Hypoxia and Nutrient Deprivation on Islets and SCIPC Cell Death
(A) SCIPC, human islets, and mouse islets were cultured at different densities for 6 hr as described in Experimental Procedures. Percentages
of PI+ dead cells were quantified using flow cytometry. Data are a compilation of results from five independent experiments (SCIPC: n = 12,
10, 6; human islets: n = 6 at each density; mouse islets: n = 9 at each density).
(B) SCIPC and mouse islets were cultured in complete or diluted RPMI medium for 6 hr. Cell viability was quantified as described in (A). Data
are a compilation of results from four independent experiments (SCIPC: n = 9 per condition; mouse islets: n = 4 per condition). For (A) and
(B), statistical significance of the differences among each cell type at different densities is determined using one-way ANOVA with Holm-
Sidak multiple comparisons.
(C) GSIS was measured using mouse islets after 6-hr low-density and high-density cultures. Data are a compilation of results from three
independent experiments with paired low- and high-density cultured islets (n = 3 per group). Statistical difference was calculated using
two-way ANOVA with Sidak’s multiple comparisons test.
(D) Stimulation index of mouse islets shown in (C). A two-tailed paired t test was used to determine statistical significance of the
difference (p = 0.0020).
(E) SCIPC, human islets, and mouse islets were cultured for 24 hr in the presence of 21% or 1% oxygen. At the end of the experiment cell
viability was measured as described in (A). Data are a compilation of results from three independent experiments (n = 6–7 per condition for
each cell type). Statistical significance of the difference between 21% and 1% oxygen for each cell type was calculated using an unpaired t
test with Welch’s correction.
(F) SCIPC, human islets, and mouse islets cultured for 24 hr at various densities with 1% or 21% oxygen. At the end of the experiment cell
viability was measured as described in (A). Data are a compilation of results from three independent experiments (n = 6 per condition for
each cell type). Statistical difference was calculated using one-way ANOVA with Holm-Sidak multiple comparisons.
All data are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns, not significant.found a significantly lower percentage of SCIPC and islet
cells with phosphorylated S6 (pS6), a downstream target
of mTOR, under nutrient-limiting conditions (Figure 4A),
correlating with reduced cell survival (Figure 4B). Alanine
supplementation restored pS6 levels in SCIPC and mouse
islets cultured at high density and prevented cell death.
Addition of rapamycin, an inhibitor of mTOR, reduced
pS6 below the levels seen in high-density cultures with or
without alanine supplementation, but did not abrogate
the protective effect of alanine on SCIPC and islet survival.810 Stem Cell Reports j Vol. 9 j 807–819 j September 12, 2017Moreover, rapamycin alone promoted SCIPC and mouse
islet survival in high-density cultures (Figure 4B). These re-
sults show that protection by alanine is independent of
mTOR- and pS6-regulated cellular processes in SCIPC and
mouse islets.
In addition to serving as cellular building blocks, amino
acids can help to sustain cellular metabolism via anaple-
rosis, serving as substrates for replenishing tricarboxylic
acid (TCA) cycle intermediates. For example, alanine, tryp-
tophan, and cysteine can be converted into pyruvate and
AB
C
Figure 3. Effect of Nutrient Supplemen-
tation on Islet Cell Death In Vitro
(A) SCIPC and mouse islets were cultured
at various densities in complete RPMI
with or without addition of glucose. Cell
viability was quantified using PI staining
via flow cytometry. Data are a compilation
of results from three independent experi-
ments (SCIPC: n = 9 per group; mouse:
n = 12 per group).
(B) Mouse islet survival in high-density
cultures supplemented with selected amino
acids. Ala, alanine; Gln, glutamine; Cys,
cysteine; Trp, tryptophan; Leu, leucine;
Met, methionine. Data are a compilation of
results from three independent experiments
(n = 9 per condition).
(C) SCIPC and human islet survival in high-
density cultures (SCIPC: 3,000 clusters/mL;
human islets: 1,000 islets/mL) supple-
mented with selected amino acids. Cell
viability was quantified as described in
(A). Data are a compilation of results from
three independent experiments (n = 9 per
condition).
For all panels, statistical significance of
differences from the high-density condition
of the same cell type was determined using
one-way ANOVA with Holm-Sidak multiple
comparisons. All data are expressed as
mean ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001, ****p < 0.0001; ns, not significant.then to the TCA cycle intermediate oxaloacetate. To test
whether enhancing anaplerosis can protect islets and
SCIPC against nutrient deprivation, we supplemented
high-density cultures with pyruvate. We found that pyru-
vate efficiently rescued SCIPC and mouse islets against
cell death, supporting the notion that sustaining the TCA
cycle may be essential for b cell survival under nutrient-
limiting conditions (Figure 5).
Mitigating Hypoxia-Induced Cell Death In Vitro
Upon transplantation, grafted cells experience a sudden
decrease in oxygen availability, from atmospheric oxygen
concentration of 21% to less than 1% in the grafts
(Carlsson et al., 2001). Oxygen levels in the native pancreas
are estimated to be 5% (Carlsson et al., 1998). We hypoth-
esize that adjusting to physiological oxygen levels of 5%
during SCIPC differentiation may reduce the impact ofhypoxia after transplantation. We therefore transitioned
differentiating cultures from 21% to 5% oxygen on day
10, before the induction of endocrine differentiation (Fig-
ure 6A) (Russ et al., 2015). Percentages of pancreatic and
duodenal homeobox 1 (PDX1)+ C-peptide+ andHomeobox
protein 6.1 (NKX6.1)+ C-peptide+ cells were comparable be-
tween SCIPC differentiated at 21% oxygen throughout
(SCIPC21%), and SCIPC differentiated with 5% oxygen
from day 10 onward (SCIPC5%) (Figure 6B), indicating
that transition to 5% oxygen at the progenitor stage of
direct differentiation did not affect the differentiation effi-
ciency of SCIPC.
We next compared the metabolic profiles SCIPC5%,
SCIPC21%, human islets, and mouse islets. We quantified
oxygen consumption rate (OCR), a measurement of mito-
chondrial respiration, and extracellular acidification rate
(ECAR), a measurement of glycolysis. SCIPC21% exhibitedStem Cell Reports j Vol. 9 j 807–819 j September 12, 2017 811
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Figure 4. Effect of mTOR on Amino Acid Rescue of Islet Survival
under Nutrient Deprivation
(A) Percentage of cells with phosphorylated S6 (pS6) in SCIPC and
mouse islets cultured in various conditions were determined using
intracellular staining and flow cytometry (n = 6 per condition for
SCIPC; n = 9 per condition for mouse islets).
(B) SCIPC and mouse islet viability in various conditions were
measured using PI staining and flow cytometry.
In both panels, data are a compilation of results from three inde-
pendent experiments (n = 6 per condition for SCIPC; n = 9 per
condition for mouse islets). One-way ANOVA with Holm-Sidak
multiple comparisons was used to determine statistical significance
of differences from the low-density condition (A) or high-density
condition (B). All data are expressed as mean ± SEM. **p < 0.01,
***p < 0.001, ****p < 0.0001; ns, not significant.significantly elevated basal OCR and ECAR when com-
pared with mouse and human islets. SCIPC5% showed
reduced OCR and ECAR when compared with SCIPC21%
(Figure 6C). These results show that the metabolic state of
SCIPC5% more closely resembles that of mature islets
when compared with SCIPC21%. Moreover, SCIPC5% were
significantly more resistant to challenges with 1% oxygen,
high-density cultures, and the combination of the two
(Figure 6D). These results suggest that SCIPC5% may sur-
vive better in vivo after transplantation.
Extreme hypoxia induces permanent changes in glucose
sensing of b cells by altering expression of genes involved in812 Stem Cell Reports j Vol. 9 j 807–819 j September 12, 2017glucosemetabolism, leading to decoupling of glucose expo-
sure and insulin secretion (Cantley et al., 2013). Thus, we
examined the expression of hypoxia-induced genes in
SCIPC5% and SCIPC21% after exposure to 1% oxygen for
18 hr. Consistent with previous reports, SCIPC21% exposed
to 1% oxygen showed dramatic increase of hypoxia-
induced gene transcripts GLUT1, HK2, PDK1, VEGF-A,
LDHA, and MCT4 (Figure 6C). In comparison, SCIPC5%
exhibited a significantly blunted response to 1% oxygen
challenge, indicating an increased resistance to hypoxic re-
programing. In vitro functional assessments showed similar
GSIS by SCIPC21% and SCIPC5% before hypoxic exposure
(Figure 6E). However, after 18 hr of hypoxia, SCIPC21%
failed to respond to glucose stimulation, whereas function-
ality of SCIPC5% was preserved (Figure 6E). Taken together,
these results indicate that differentiation of SCIPC at a
physiological oxygen concentration of 5% results in a pro-
tective adaptation without impairing differentiation or
function.Promoting SCIPC Survival after Transplant
Our in vitro results thus far suggest that generation of SCIPC
at 5%oxygen aloneor in combinationwith amino acid sup-
plementationmay protect against ischemia after transplan-
tation. Hence, we transplanted SCIPC5% or SCIPC21% with
or without amino acid supplementation in SQ space and
monitored graft survival using bioluminescent imaging
(Figure 7A). In these experiments, we used a stringent crite-
rion of maintenance of more than 80% of the initial cell
mass to define graft survival. Most of the control SCIPC21%
without amino acid supplementation rapidly dropped
below this threshold. SCIPC5% without amino acid supple-
mentation showed improved survival early after transplant,
but theprotective effect fadedbyday 10, resulting in overall
survival similar to that of the SCIPC21% control (Figure 7B).
Glutamine and alanine supplementation to SCIPC21% also
showed improvement early after transplant, but thisprotec-
tive effect did not persist. Combining SCIPC5% with amino
acid supplementation significantly improved graft survival,
with 75% of grafts surviving to day 20 (Figure 7B). The
SCIPC5% + amino acid group not only have better graft
mass but also better preservation of insulin-producing cells
when compared with the other groups (Figure 7C). Taken
together, these results suggest that hypoxia and nutrient
deprivation are two major contributors of SCIPC graft loss
after transplantation and mitigating both factors is needed
to preserve SCIPC graft mass after transplant.DISCUSSION
Graft survival is amajor barrier to islet transplantation, and
its impact on stem cell-derived b cell replacement therapy
Figure 5. Effect of Pyruvate on Islet and SCIPC Cell Death
during Nutrient Deprivation
Various concentrations of sodium pyruvate were added to high-
density SCIPC, human islet, and mouse islet cultures, and viability
was measured using PI staining and flow cytometry. Data are ex-
pressed as mean ± SEM and are a compilation of results from three
independent experiments (SCIPC: n = 9; human islets: n = 9–12;
mouse islets: n = 6–9). One-way ANOVA with Holm-Sidak multiple
comparisons was used to determine the statistical significance of
the differences from the high-density condition. ****p < 0.0001.is unclear. In this study, we demonstrate a significant
decline of SCIPC graft mass shortly after transplant with
a preferential loss of more mature insulin-producing cells.
Although SCIPC aremore resistant to hypoxia and nutrient
deprivation individually when compared with mature is-
lets, they are vulnerable to their combined action. We
have developed strategies for mitigating the impact of
ischemia to achieve greater retention of SCIPC graft mass
after transplant. Our results suggest that effective therapeu-
tic applications of SCIPC should incorporate strategies to
mitigate the impact of hypoxia and nutrient deprivation
for promoting graft survival after transplant. Importantly,
the concepts and the approaches presented in this study
may be applicable to other stem cell-based therapies.
It is well known that b cells in mature islets are sensitive
to ischemia and that the majority of them die shortly after
transplantation (Emamaullee and Shapiro, 2007; Potter
et al., 2014; Rickels et al., 2005). Previous studies
comparing adult islets and fetal islet-like cells have shown
better survival of fetal cells due to their ability to withstand
ischemia and to replenish graft mass by proliferation (Beat-
tie et al., 1997; Hayek and Beattie, 1997). These findings
have kindled the hope that SCIPC would be similarly resis-
tant to ischemia, thus providing a solution to the islet graft
survival problem. Indeed, survival and continued differen-
tiation of pancreatic progenitor cells after transplantation
has been demonstrated (Bruin et al., 2013; Kroon et al.,
2008; Vegas et al., 2016). However, some experimental ev-
idence suggests that consistent engraftment of pancreatic
progenitor cells is challenging to achieve (Courtney et al.,2010; Matveyenko et al., 2010). Our side-by-side quantita-
tive comparisons showed that SCIPC indeed survived bet-
ter thanmature islets after transplant, although substantial
graftmasswas still lost.Moreover, themoremature insulin-
producing cells among SCIPC preparations were preferen-
tially lost after transplant. The increased vulnerability of
more mature insulin-producing cells may be due to prefer-
ential death or de-differentiation of more mature cells un-
der ischemia. Previous studies have shown that hypoxia
can induce de-differentiation (Puri et al., 2015). The com-
bined effect of cell death and de-differentiation may
explain the inconsistent results with SCIPC grafts and the
long duration needed to achieve graft function reported
previously (Kroon et al., 2008; Matveyenko et al., 2010).
There are currently two general experimental approaches
to the control of hypoxia-induced death of mature b cells
from islets: preconditioning before transplant or provision
of oxygen after transplant. Preconditioning is based on the
concept that cells can adapt to survive under low oxygen
tensions if the change is introduced gradually (Abaci
et al., 2010; Hals et al., 2015). Moreover, transient hypoxia
induces hypoxia-induced factor (HIF) that promotes angio-
genesis (Pugh and Ratcliffe, 2003), which benefits long-
term graft function. Artificial induction of HIF-1a improves
transplant outcomes (Faleo et al., 2008; Stokes et al., 2013).
The current process of islet transplantation extracts islets
from native pancreas with 5% O2 and rests them at atmo-
spheric 21% O2 for a few days before infusing them into
the portal vein with 1–2% O2. The abruptness of going
from supraphysiological oxygen tension to hypoxia de-
prives the cells time to adapt. Preconditioning the islets
using pulsatile cycles of 5–21% oxygen levels for 1 hr helps
to maintain islet function during later exposure to hypoxia
in vitro (Lo et al., 2012). These results argue that exposure to
hypoxia can be beneficial for long-term survival and func-
tion of islet and SCIPC grafts. However, dropping oxygen
tension too low for too long may kill islets and change
the metabolic program of surviving cells, leading to long-
term dysfunction (Cantley et al., 2013; Smith et al.,
2017). Thus, the challenge is to define the proper condi-
tions under which to prepare the cells to withstand hypox-
ia without metabolic reprogramming.
Current stem cell differentiation protocols are carried out
at supraphysiological oxygen levels of 21% instead of the
physiological oxygen tension in the naive pancreas of
5%.We reasoned that acclimatizing SCIPC to physiological
5% oxygen tension will provide protection from hypoxia-
induced cell death upon transplantation. Encouragingly,
transitioning cultures to 5% oxygen after 10 days of
differentiation did not negatively affect SCIPC genera-
tion, and adjusted their metabolic profile to those observed
in mature islets. Lower metabolic demand of SCIPC5%
could be responsible for their higher resilience underStem Cell Reports j Vol. 9 j 807–819 j September 12, 2017 813
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Figure 6. Generation of SCIPC at 5% Oxygen
(A) Schematic for the differentiation of SCIPC with 21% or 5% oxygen (referred to as SCIPC21% and SCIPC5%, respectively).
(B) Representative flow plots of SCIPC21% and SCIPC5% from three independent experiments are shown, and mean ± SEM of percentages of
cells are listed in the upper right quadrants (n = 6 per condition).
(C) OCR and ECAR of SCIPC21% (n = 11), SCIPC5% (n = 6), human islet (n = 13), and mouse islet (n = 9) cultures were measured at 21% oxygen
level. Data are a summary of three independent experiments with individual data points, mean, and SEM shown. Statistical significance of
the differences of the means was determined using one-way ANOVA Holm-Sidak multiple comparisons test.
(D) SCIPC21% and SCIPC5% were cultured in high- or low-density (20 and 3,000 clusters/mL) with 21% or 1% oxygen for 24 hr. Cell viability
was measured using PI staining and flow cytometry. Data are expressed as mean ± SEM and are a compilation of results from three in-
dependent experiments (SCIPC21%: n = 6–10; SCIPC5%: n = 10–16). An unpaired t test with Welch’s correction was used to compare the two
groups.
(E) qPCR analysis of expression of hypoxia-induced gene transcripts in SCIPC21% or SCIPC5% after 18-hr exposure to 1% oxygen. Results
are expressed as fold change over pre-exposure baseline after normalization to the housekeeping gene GAPDH. Values are mean ± SEM with
n = 3 for each cell type. Statistical significance of the difference between the two cell types across all 10 genes was determined using a
paired t test (p = 0.0192).
(legend continued on next page)
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Figure 7. Effect of Amino Acid Supplementation and Oxygen Acclimatization on SCIPC Survival after Transplantation
(A) Representative bioluminescence images of SCIPC transplanted subcutaneously into non-diabetic NSG mice at days 0 and 20.
(B) Graft survival over time after transplantation of SCIPC21% (n = 10), SCIPC5% (n = 11), SCIPC21% + amino acid (aa) (n = 8), and SCIPC5% +
aa (n = 8). Grafts were considered ‘‘failed’’ when the BLI dropped below 80% of day 0. Significance of differences in survival from SCIPC21%
without supplement was determined for each experimental condition using a log-rank (Mantel-Cox) test.
(C) Top: representative images of insulin staining of SCIPC grafts in (B) collected on day 20. Scale bars, 200 mm. Bottom: magnified views
of the insets in the larger images. Scale bars, 50 mm. DAPI (blue), insulin (red).conditions of hypoxia and nutrient deprivation. Impor-
tantly, SCIPC5% showedmuch-attenuated response to later
encounter of extreme hypoxia of 1% oxygen and, most
importantly, SCIPC5% remain functional after hypoxic
exposure while SCIPC21% do not. Thus, generating SCIPC
at physiological oxygen tension appears to achieve a
balance of inducing protection against hypoxia without
impairing the SCIPC developmentally or functionally.
One other major conclusion from this study is that
nutrient deprivation, another consequence of ischemia,
can also kill islets and SCIPC and contribute to poor
outcomes after transplant. In searching for a strategy to(F) GSIS of SCIPC21% and SCIPC5% before and after 18-hr exposure
Statistical significance of the differences among all conditions was
parisons test.
All data are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p <mitigate the impact of nutrient deprivation on islet and
SCIPC survival, we found some amino acids to be effective.
It is important to note that this newly identified role of
amino acids in sustaining b cell viability under nutrient
deprivation is distinct from the previously reported effect
of amino acids in potentiating b cell insulin secretion
upon glucose stimulation (Newsholme et al., 2007; Prentki
et al., 2013). Two features of amino acid-mediated rescue
are important: single amino acid supplementation can be
sufficient and not all amino acids work. Furthermore, our
study suggests that amino acids likely protect b cells by sus-
taining mitochondria oxidation via anaplerosis instead ofto 1% oxygen. Stimulation indexes are shown (n = 3 per group).
determined using one-way ANOVA with Holm-Sidak multiple com-
0.001, ****p < 0.0001; ns, not significant.
Stem Cell Reports j Vol. 9 j 807–819 j September 12, 2017 815
mTOR-dependent anabolism. However, most amino acids
can enter the TCA cycle, but not all equally protect islets
and SCIPC against nutrient deprivation. In addition,
glucose also has anaplerotic effects, but did not confer
any protection at a wide range of concentrations tested.
Entrance to cells andmitochondria and activities of specific
anaplerotic enzymes may impose limitations on some nu-
trients to become TCA intermediates. Definitive demon-
stration of anaplerosis and/or amino acid oxidation in is-
lets and SCIPC will require comprehensive metabolic
profiling that is currently ongoing in our laboratories.
These efforts may shed light on the mechanisms of amino
acid rescue of islets and SCIPC under nutrient deprivation
and help to guide optimized strategy to support islet and
SCIPC survival after transplant.
The surprising finding that rapamycin alone sustained
SCIPC and islet survival under nutrient deprivation suggests
that limiting protein synthesis under nutrient deprivation
may be protective by reserving the cellular pool of amino
acids. In this regard, short 2-hr rapamycin exposure has
been shown to improve cell viability of human liver carci-
noma HepG2 cells and human embryonic kidney HEK293
cells via induction of autophagy (Kapuy et al., 2014). Auto-
phagy is a cell-intrinsic adaptation strategy to starvation by
breaking down proteins to fuel basal survival needs (Miz-
ushima and Komatsu, 2011). However, longer 24- to 48-hr
treatment of rapamycin impairs islet survival despite induc-
tion of autophagy (Tanemura et al., 2012). Thus, although
islets have the ability to adapt to nutrient deprivation by
autophagy, this catabolic survival mechanism is likely un-
sustainable. Supplementation of critical nutrients will likely
be amore effective approach to sustain islets and SCIPC sur-
vival after transplant until revascularization.
Glutamine and alanine are the two most abundant
amino acids in plasma (Curi et al., 2005). The highest levels
of alanine have been found in the endocrine system,
including islets (Ota et al., 2014). Islets normally have a
high demand for glutamine and alanine (Dixon et al.,
2003). During whole-body starvation, muscle breakdown
provides a source of glutamine and alanine to support
cellular functions (Chang and Goldberg, 1978). Therefore,
supplementation of glutamine and alanine to transplanted
islets and SCIPC may mimic the physiological response to
endure nutrient deprivation.
Our in vivo results of greatly improved SCIPC survival by
combining physiological oxygen acclimatization and
amino acid supplementation suggest that hypoxia and
nutrient deprivation are likely the twomost important con-
tributors to SCIPC death after transplant. These experi-
mentsmainly focused on cell viability, because cell survival
is a prerequisite to function and needs to be addressed first.
It is encouraging that this approach not only sustained cell
viability but also insulin expression, suggesting functional816 Stem Cell Reports j Vol. 9 j 807–819 j September 12, 2017preservation. Future studies are needed to evaluate this
strategy in a diabetes model. Overall, our study demon-
strates that by addressing individual contributors of
ischemia-induced SCIPC death, dramatic improvement of
SCIPC engraftment can be achieved. The general strategy
of physiological oxygen acclimatization and nutrient sup-
plementation may be applicable to other stem cell-derived
grafts to improve their survival and therapeutic efficacy.EXPERIMENTAL PROCEDURES
All animal procedures were performed under approved protocols
and in accordance with ethical guidelines by the Institutional
Animal Care and Use Committee (IACUC) at the University of
California, San Francisco.
In Vitro Ischemia Simulations
SCIPC, human islets, and mouse islets were cultured at increasing
densities in RPMImediawith 5% fetal calf serum (R5) for 6–24hr to
simulate decreasing nutrients. SCIPC were cultured in concentra-
tions of 200 clusters/mL for low density (LD), 1,500 clusters/mL
for medium density (MD), and 3,000 clusters/mL for high density
(HD). Mouse and human islets were cultured at concentration of
200 islets/mL for LD, 500 islets/mL for MD, and 1,000 islets/mL
for HD. Alternatively, SCIPC, human islets, and mouse islets
were cultured with 1% and 10% R5 diluted in PBS for 6–24 hr to
simulate nutrient deprivation. For the hypoxia challenges, SCIPC,
human islets, andmouse isletswere cultured in R5with 1%oxygen
in incubators with adjustable oxygen levels (Heracell 240, Thermo
Fisher Scientific, Waltham, MA).
Islet and SCIPC Transplantation
Transplantation of mouse islets and SCIPC into renal capsules
or the subcutaneous space was performed as reported previously
(Halberstadt et al., 2005; Szot et al., 2007). For amino acid supple-
mentation, additional 10 mM alanine and 10 mM glutamine were
supplemented to SCIPC culture medium 2 hr before the cells were
collected for transplant. SCIPC were transplanted subcutaneously
together with 50 mL of the alanine- and glutamine-supplemented
media.
Other experimental procedures are described in Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2017.07.012.
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